Companies

Cue Biopharma, Inc. (CUE) SEC filings

CIK 0001645460 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)27.5 M5.5 M1.2 M
Net income (USD)-26.6 M-50.7 M-53.0 M
Diluted EPS (USD/shares)-0.28-1.11-1.49

Latest filings

FiledFormDescriptionPeriod
2026-10-14442026-10-12
2026-10-14442026-10-12
2026-10-14442026-10-12
2026-10-13144144
2026-10-13144144
2026-10-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-218-K8-K items 7.01,8.01,9.012026-09-20
2026-08-284/A4/A2026-07-09
2026-08-284/A4/A2026-07-09
2026-08-21SCHEDULE 13DSCHEDULE 13D
2026-08-20EFFECTEFFECT items ,,
2026-08-18CORRESPCORRESP
2026-08-17442026-08-13
2026-08-17442026-08-13
2026-08-17UPLOADUPLOAD
2026-08-14442026-08-12
2026-08-14144144
2026-08-1410-Q10-Q2026-06-30
2026-08-148-K8-K items 2.022026-08-14
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-13144144
2026-08-12S-3S-3
2026-08-038-K8-K items 5.022026-07-27
2026-08-03442026-07-30
2026-08-03332026-07-30

Forms on file (last 1,000): 4 214, 8-K 82, 3 36, 10-Q 26, CORRESP 15, UPLOAD 15, SC 13G 13, DEFA14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CUE (0.002 USD), /gw/filings/filings?ticker=CUE&form=8-K, /gw/filings/facts?ticker=CUE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange